Marcela Araújo Pereira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marcela Araújo Pereira has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Isabella Macário Ferro Cavalcanti
Federal University of Pernambuco (UFPE)
4 shared publications - Nereide Stela Santos-Magalhães
Keizo Asami Institute, iLIKA, Federal University of Pernambuco Recife Brazil
4 shared publications - Rafaela de Siqueira Ferraz Carvalho
Universidade Federal de Pernambuco
3 shared publications - Fiamma Acsa de Siqueira Araújo
Universidade Federal de Pernambuco
2 shared publications - Pabyton Gonçalves Cadena
Universidade Federal Rural de Pernambuco
2 shared publications - René Duarte Martins
Universidade Federal de Pernambuco, Brasil
2 shared publications
Latest Publications
- Open Access
- 6 February 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (3)
Ação da Lippia sidoides Cham nas infecções de faringe, cavidade oral e problemas odontológicos: uma revisão de literatura
The aim of this study was to review the literature on the use of the plant Lippia sidoides Cham in the treatment of pharyngeal and oral cavity infections. Thus, a literature search was carried out based on articles indexed in international virtual libraries, Scientific Electronic Library Online (SciELO), U.S. National Library of Medicine (PubMed), Academic Google and Capes Journal Portal. The descriptors used were: Lippia sidoides Cham, infections of the pharynx and oral cavity, and their English counterparts. Lippia sidoides Cham belongs to the verbenaceae family and is popularly known as pepper rosemary. In folk medicine, this plant is mainly used as an infusion to treat infections of the mouth and throat. The therapeutic properties of this plant are related to the major constituents carvacrol and thymol, since these molecules have anti-inflammatory, antioxidant, antifungal and antibacterial action. The studies prove the antibacterial and antifungal properties of the extracts and essential oil of this plant against cariogenic bacteria strains, such as Streptococcus mutans and against strains of different Candida species, which is the main fungus related to infections in the oral cavity. However, although Lippia sidoides Cham is used in traditional medicine for the treatment of infections related to the pharynx, data and clinical studies to support this practice are lacking. Thus, it is concluded that the extract of the plant Lippia sidoides Cham is widely used and marketed for infections related to the pharynx, oral cavity and dental problems.
- 6 February 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (3)
Open AccessAção da Lippia sidoides Cham nas infecções de faringe, cavidade oral e problemas odontológicos: uma revisão de literatura
The aim of this study was to review the literature on the use of the plant Lippia sidoides Cham in the treatment of pharyngeal and oral cavity infections. Thus, a literature search was carried out based on articles indexed in international virtual libraries, Scientific Electronic Library Online (SciELO), U.S. National Library of Medicine (PubMed), Academic Google and Capes Journal Portal. The descriptors used were: Lippia sidoides Cham, infections of the pharynx and oral cavity, and their English counterparts. Lippia sidoides Cham belongs to the verbenaceae family and is popularly known as pepper rosemary. In folk medicine, this plant is mainly used as an infusion to treat infections of the mouth and throat. The therapeutic properties of this plant are related to the major constituents carvacrol and thymol, since these molecules have anti-inflammatory, antioxidant, antifungal and antibacterial action. The studies prove the antibacterial and antifungal properties of the extracts and essential oil of this plant against cariogenic bacteria strains, such as Streptococcus mutans and against strains of different Candida species, which is the main fungus related to infections in the oral cavity. However, although Lippia sidoides Cham is used in traditional medicine for the treatment of infections related to the pharynx, data and clinical studies to support this practice are lacking. Thus, it is concluded that the extract of the plant Lippia sidoides Cham is widely used and marketed for infections related to the pharynx, oral cavity and dental problems.
- Open Access
- 4 December 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (16)
Ação de Justicia pectoralis Jacq. (Acanthaceae) no tratamento de infecções do trato respiratório: uma revisão de literatura
Há milhares de anos a humanidade a fim de garantir a sua sobrevivência, utilizava as plantas em seu cotidiano para auxiliar na cura e no tratamento de diversas patologias. Essa prática médica integrativa é conhecida como fitoterapia e vem crescendo ao longo dos anos como uma alternativa complementar bastante promissora. Diversos extratos apresentam um amplo espectro de ação profilática frente a várias infecções, assim Justicia pectoralis Jacq. (Acanthaceae) é uma erva medicinal encontrada em diversos países da América, conhecida no Brasil popularmente como “chambá”, “anador” ou “trevo-cumaru”, sendo bastante empregada no tratamento de distúrbios respiratórios como tosse, asma e bronquite. Assim, o objetivo desse estudo foi realizar uma revisão da literatura sobre a ação de Justicia pectoralis no tratamento de infecções do trato respiratório. Inicialmente, foi realizada uma busca por artigos indexados nas bases de dados Lilacs, PubMed, Google Acadêmico, ScienceDirect, Scielo e Medline publicados entre os anos de 2010 a 2020 nos idiomas português, inglês e espanhol. O extrato de Justicia pectoralis apresenta atividade frente a várias bactérias, dentre elas, algumas que provocam infecções do trato respiratório como, por exemplo, Acinetobacter baumannii, Klebsiella pneumoniae e Staphylococcus aureus. A 1,2 benzopirona e a 7-hidroxicumarina são os fitocompostos majoritários dessa planta responsáveis pelas ações anti-inflamatórias, broncodiladoras, anti-histamínicas e analgésicas que contribuem no alívio dos sintomas das infecções respiratórias. Por fim, uma vez que Justicia pectoralis Jacq. (Acanthaceae) já possui ampla utilização na medicina popular e importantes destas atividades se correlacionam com os achados in vitro, faz-se necessário o aprofundamento de estudos que direcionem para o futuro uso clínico desta espécie.
- 4 December 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (16)
Open AccessAção de Justicia pectoralis Jacq. (Acanthaceae) no tratamento de infecções do trato respiratório: uma revisão de literatura
Há milhares de anos a humanidade a fim de garantir a sua sobrevivência, utilizava as plantas em seu cotidiano para auxiliar na cura e no tratamento de diversas patologias. Essa prática médica integrativa é conhecida como fitoterapia e vem crescendo ao longo dos anos como uma alternativa complementar bastante promissora. Diversos extratos apresentam um amplo espectro de ação profilática frente a várias infecções, assim Justicia pectoralis Jacq. (Acanthaceae) é uma erva medicinal encontrada em diversos países da América, conhecida no Brasil popularmente como “chambá”, “anador” ou “trevo-cumaru”, sendo bastante empregada no tratamento de distúrbios respiratórios como tosse, asma e bronquite. Assim, o objetivo desse estudo foi realizar uma revisão da literatura sobre a ação de Justicia pectoralis no tratamento de infecções do trato respiratório. Inicialmente, foi realizada uma busca por artigos indexados nas bases de dados Lilacs, PubMed, Google Acadêmico, ScienceDirect, Scielo e Medline publicados entre os anos de 2010 a 2020 nos idiomas português, inglês e espanhol. O extrato de Justicia pectoralis apresenta atividade frente a várias bactérias, dentre elas, algumas que provocam infecções do trato respiratório como, por exemplo, Acinetobacter baumannii, Klebsiella pneumoniae e Staphylococcus aureus. A 1,2 benzopirona e a 7-hidroxicumarina são os fitocompostos majoritários dessa planta responsáveis pelas ações anti-inflamatórias, broncodiladoras, anti-histamínicas e analgésicas que contribuem no alívio dos sintomas das infecções respiratórias. Por fim, uma vez que Justicia pectoralis Jacq. (Acanthaceae) já possui ampla utilização na medicina popular e importantes destas atividades se correlacionam com os achados in vitro, faz-se necessário o aprofundamento de estudos que direcionem para o futuro uso clínico desta espécie.
- Open Access
- 17 May 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (6)
Interaction between bark extract of Anadenanthera colubrina var. cebil (Griseb.) Altschul with antibiotics against methicillin-resistant Staphylococcus aureus (MRSA)
Anadenanthera colubrina var. cebil (Griseb.) Altschul, a plant often found in areas of the Caatinga in northeastern Brazil, is widely used in unconventional medicine for the treatment of infections and inflammations. Thus, the aim of the present study was to evaluate the antibacterial activity of A. colubrina bark extracts against methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates, to investigate if intact and regenerated bark extracts have the same effect against MRSA and to determine the interaction between these extracts and antibiotics. The antibacterial activity was performed by the determination of the minimum inhibitory concentration (MIC) according to the Clinical and Laboratory Standards Institute (CLSI) and the interaction assay was performed by the checkerboard method. A. colubrina extracts showed bacteriostatic activity (MIC = 8-32 mg/L) against MRSA clinical strains and no difference was found in antibacterial activity between intact and regenerated barks, suggesting that even after regeneration, the barks of this species have the same antibacterial activity. Moreover, the in vitro interaction of A. colubrina extracts with ciprofloxacin or erythromycin was additive (FICI = 0.52). Thus, the bark extracts of Anadenanthera colubrina exhibit antibacterial activity and can be used alone or in combination with antibiotics against MRSA clinical isolates.
- 17 May 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (6)
Open AccessInteraction between bark extract of Anadenanthera colubrina var. cebil (Griseb.) Altschul with antibiotics against methicillin-resistant Staphylococcus aureus (MRSA)
Anadenanthera colubrina var. cebil (Griseb.) Altschul, a plant often found in areas of the Caatinga in northeastern Brazil, is widely used in unconventional medicine for the treatment of infections and inflammations. Thus, the aim of the present study was to evaluate the antibacterial activity of A. colubrina bark extracts against methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates, to investigate if intact and regenerated bark extracts have the same effect against MRSA and to determine the interaction between these extracts and antibiotics. The antibacterial activity was performed by the determination of the minimum inhibitory concentration (MIC) according to the Clinical and Laboratory Standards Institute (CLSI) and the interaction assay was performed by the checkerboard method. A. colubrina extracts showed bacteriostatic activity (MIC = 8-32 mg/L) against MRSA clinical strains and no difference was found in antibacterial activity between intact and regenerated barks, suggesting that even after regeneration, the barks of this species have the same antibacterial activity. Moreover, the in vitro interaction of A. colubrina extracts with ciprofloxacin or erythromycin was additive (FICI = 0.52). Thus, the bark extracts of Anadenanthera colubrina exhibit antibacterial activity and can be used alone or in combination with antibiotics against MRSA clinical isolates.
- 1 September 2016
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 231, 55-62
Cationic liposomes containing antioxidants reduces pulmonary injury in experimental model of sepsis
- 1 September 2016
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 231, 55-62
Cationic liposomes containing antioxidants reduces pulmonary injury in experimental model of sepsis
- Open Access
- 29 April 2016
- Published by FapUNIFESP (SciELO) in Memórias do Instituto Oswaldo Cruz
- Vol. 111 (5) , 330-334
Effects of the encapsulation of usnic acid into liposomes and interactions with antituberculous agents against multidrug-resistant tuberculosis clinical isolates
Mycobacterium tuberculosis (Mtb) has acquired resistance and consequently the antibiotic therapeutic options available against this microorganism are limited. In this scenario, the use of usnic acid (UA), a natural compound, encapsulated into liposomes is proposed as a new approach in multidrug-resistant tuberculosis (MDR-TB) therapy. Thus the aim of this study was to evaluate the effect of the encapsulation of UA into liposomes, as well as its combination with antituberculous agents such as rifampicin (RIF) and isoniazid (INH) against MDR-TB clinical isolates. The in vitro antimycobacterial activity of UA-loaded liposomes (UA-Lipo) against MDR-TB was assessed by the microdilution method. The in vitro interaction of UA with antituberculous agents was carried out using checkerboard method. Minimal inhibitory concentration values were 31.25 and 0.98 µg/mL for UA and UA-Lipo, respectively. The results exhibited a synergistic interaction between RIF and UA [fractional inhibitory concentration index (FICI) = 0.31] or UA-Lipo (FICI = 0.28). Regarding INH, the combination of UA or UA-Lipo revealed no marked effect (FICI = 1.30-2.50). The UA-Lipo may be used as a dosage form to improve the antimycobacterial activity of RIF, a first-line drug for the treatment of infections caused by Mtb.
- 29 April 2016
- Published by FapUNIFESP (SciELO) in Memórias do Instituto Oswaldo Cruz
- Vol. 111 (5) , 330-334
Open AccessEffects of the encapsulation of usnic acid into liposomes and interactions with antituberculous agents against multidrug-resistant tuberculosis clinical isolates
Mycobacterium tuberculosis (Mtb) has acquired resistance and consequently the antibiotic therapeutic options available against this microorganism are limited. In this scenario, the use of usnic acid (UA), a natural compound, encapsulated into liposomes is proposed as a new approach in multidrug-resistant tuberculosis (MDR-TB) therapy. Thus the aim of this study was to evaluate the effect of the encapsulation of UA into liposomes, as well as its combination with antituberculous agents such as rifampicin (RIF) and isoniazid (INH) against MDR-TB clinical isolates. The in vitro antimycobacterial activity of UA-loaded liposomes (UA-Lipo) against MDR-TB was assessed by the microdilution method. The in vitro interaction of UA with antituberculous agents was carried out using checkerboard method. Minimal inhibitory concentration values were 31.25 and 0.98 µg/mL for UA and UA-Lipo, respectively. The results exhibited a synergistic interaction between RIF and UA [fractional inhibitory concentration index (FICI) = 0.31] or UA-Lipo (FICI = 0.28). Regarding INH, the combination of UA or UA-Lipo revealed no marked effect (FICI = 1.30-2.50). The UA-Lipo may be used as a dosage form to improve the antimycobacterial activity of RIF, a first-line drug for the treatment of infections caused by Mtb.
- 1 February 2013
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1828 (2) , 309-316
Nanoencapsulation of quercetin and resveratrol into elastic liposomes
- 1 February 2013
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1828 (2) , 309-316
Nanoencapsulation of quercetin and resveratrol into elastic liposomes